Effects of ferric carboxymaltose on markers of mineral and bone metabolism: a single-center prospective observational study of women with iron deficiency

BACKGROUND: Two weekly infusions of ferric carboxymaltose (FCM) are commonly prescribed for treatment of iron-deficiency anemia. However, administration of FCM increases intact levels of fibroblast growth factor 23 (FGF23), which causes hypophosphatemia due to renal phosphate wasting, calcitriol def...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Bone
Autori principali: Frazier, Rebecca, Hodakowski, Alexander, Cai, Xuan, Lee, Jungwha, Zakarija, Anaadriana, Stein, Brady, David, Valentin, Wolf, Myles, Isakova, Tamara, Mehta, Rupal
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7680361/
https://ncbi.nlm.nih.gov/pubmed/32730929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bone.2020.115559
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi